{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:52:41Z","timestamp":1767858761397,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"vetenskapsr\u00e5det","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Brown bears (<jats:italic>Ursus arctos<\/jats:italic>) hibernate for 5\u20136\u00a0months during winter, but despite kidney insufficiency, dyslipidemia and inactivity they do not seem to develop atherosclerosis or cardiovascular disease (CVD). IgM antibodies against phosphorylcholine (anti-PC) and malondialdehyde (anti-MDA) are associated with less atherosclerosis, CVD and mortality in uremia in humans and have anti-inflammatory and other potentially protective properties. PC but not MDA is exposed on different types of microorganisms. We determine anti-PC and anti-MDA in brown bears in summer and winter. Paired serum samples from 12 free ranging Swedish brown bears were collected during hibernation in winter and during active state in summer and analyzed for IgM, IgG, IgG1\/2 and IgA anti-PC and anti-MDA by enzyme linked immunosorbent assay (ELISA). When determined as arbitrary units (median set at 100 for summer samples), significantly raised levels were observed in winter for anti-PC subclasses and isotypes, and for IgA anti-PC the difference was striking; 100 IQR (85.9\u2013107.9) vs 782.3, IQR (422.8\u20131586.0; p\u2009&lt;\u20090.001). In contrast, subclasses and isotypes of anti-MDA were significantly lower in winter except IgA anti-MDA, which was not detectable. Anti-PCs are significantly raised during hibernation in brown bears; especially IgA anti-PC was strikingly high. In contrast, anti-MDA titers was decreased during hibernation. Our observation may represent natural immunization with microorganisms during a vulnerable period and could have therapeutic implications for prevention of atherosclerosis.<\/jats:p>","DOI":"10.1038\/s41598-021-91679-1","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T10:16:45Z","timestamp":1623233805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Potential natural immunization against atherosclerosis in hibernating bears"],"prefix":"10.1038","volume":"11","author":[{"given":"Shailesh Kumar","family":"Samal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Fr\u00f6bert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Kindberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Frosteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"91679_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ki.2012.396","volume":"83","author":"P Stenvinkel","year":"2013","unstructured":"Stenvinkel, P., Jani, A. H. & Johnson, R. J. Hibernating bears (Ursidae): Metabolic magicians of definite interest for the nephrologist. Kidney Int. 83, 207\u2013212 (2013).","journal-title":"Kidney Int."},{"key":"91679_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/joim.12983","volume":"287","author":"O Frobert","year":"2020","unstructured":"Frobert, O., Frobert, A. M., Kindberg, J., Arnemo, J. M. & Overgaard, M. T. The brown bear as a translational model for sedentary lifestyle-related diseases. J. Intern. Med. 287, 263\u2013270 (2020).","journal-title":"J. Intern. Med."},{"key":"91679_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1752-8062.2011.00370.x","volume":"5","author":"K Arinell","year":"2012","unstructured":"Arinell, K. et al. Brown bears (Ursus arctos) seem resistant to atherosclerosis despite highly elevated plasma lipids during hibernation and active state. Clin. Transl. Sci. 5, 269\u2013272 (2012).","journal-title":"Clin. Transl. Sci."},{"key":"91679_CR4","doi-asserted-by":"publisher","first-page":"e72934","DOI":"10.1371\/journal.pone.0072934","volume":"8","author":"P Stenvinkel","year":"2013","unstructured":"Stenvinkel, P. et al. Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos). PLoS ONE 8, e72934 (2013).","journal-title":"PLoS ONE"},{"key":"91679_CR5","doi-asserted-by":"publisher","first-page":"22509","DOI":"10.1074\/jbc.M116.742916","volume":"291","author":"KG Welinder","year":"2016","unstructured":"Welinder, K. G. et al. Biochemical foundations of health and energy conservation in hibernating free-ranging subadult brown bear Ursus arctos. J. Biol. Chem. 291, 22509\u201322523 (2016).","journal-title":"J. Biol. Chem."},{"key":"91679_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frostegard","year":"2013","unstructured":"Frostegard, J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 11, 117 (2013).","journal-title":"BMC Med."},{"key":"91679_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/joim.13012","volume":"287","author":"L Dai","year":"2020","unstructured":"Dai, L. et al. Phenotypic features of vascular calcification in chronic kidney disease. J. Intern. Med. 287, 422\u2013434 (2020).","journal-title":"J. Intern. Med."},{"key":"91679_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","volume":"145","author":"J Frosteg\u00e5rd","year":"1999","unstructured":"Frosteg\u00e5rd, J. et al. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145, 33\u201343 (1999).","journal-title":"Atherosclerosis"},{"key":"91679_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","volume":"108","author":"YI Miller","year":"2011","unstructured":"Miller, Y. I. et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235\u2013248 (2011).","journal-title":"Circ. Res."},{"key":"91679_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijpara.2014.12.006","volume":"45","author":"TR Aprahamian","year":"2015","unstructured":"Aprahamian, T. R. et al. The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model. Int. J. Parasitol. 45, 203\u2013207 (2015).","journal-title":"Int. J. Parasitol."},{"key":"91679_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/187153012799278893","volume":"12","author":"L Al-Riyami","year":"2012","unstructured":"Al-Riyami, L. & Harnett, W. Immunomodulatory properties of ES-62, a phosphorylcholine-containing glycoprotein secreted by Acanthocheilonema viteae. Endocr. Metab. Immune Disord. Drug Targets 12, 45\u201352 (2012).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"91679_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/01.ATV.17.5.963","volume":"17","author":"J Frosteg\u00e5rd","year":"1997","unstructured":"Frosteg\u00e5rd, J., Huang, Y. H., R\u00f6nnelid, J. & Sch\u00e4fer-Elinder, L. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. Arterioscler. Thromb. Vasc. Biol. 17, 963\u2013968 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"91679_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","volume":"188","author":"J Su","year":"2006","unstructured":"Su, J. et al. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 188, 160\u2013166 (2006).","journal-title":"Atherosclerosis"},{"key":"91679_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jacc.2006.11.054","volume":"50","author":"G Caligiuri","year":"2007","unstructured":"Caligiuri, G. et al. Phosphorylcholine-targeting immunization reduces atherosclerosis. J. Am. Coll. Cardiol. 50, 540\u2013546 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"91679_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijcard.2012.01.018","volume":"167","author":"K Caidahl","year":"2013","unstructured":"Caidahl, K. et al. IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes. Int. J. Cardiol. 167, 464\u2013469 (2013).","journal-title":"Int. J. Cardiol."},{"key":"91679_CR16","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/ar3193","volume":"12","author":"C Anania","year":"2010","unstructured":"Anania, C. et al. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus. Arthritis Res. Ther. 12, R214 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"91679_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/rheumatology\/ken120","volume":"47","author":"J Su","year":"2008","unstructured":"Su, J. et al. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology (Oxford) 47, 1144\u20131150 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"91679_CR18","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/art.34537","volume":"64","author":"J Vas","year":"2012","unstructured":"Vas, J., Gronwall, C., Marshak-Rothstein, A. & Silverman, G. J. Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum. 64, 3388\u20133398 (2012).","journal-title":"Arthritis Rheum."},{"issue":"997\u20131005","key":"91679_CR19","first-page":"e1","volume":"58","author":"M Sobel","year":"2013","unstructured":"Sobel, M. et al. Low levels of a natural IgM antibody are associated with vein graft stenosis and failure. J Vasc. Surg. 58(997\u20131005), e1\u2013e2 (2013).","journal-title":"J Vasc. Surg."},{"key":"91679_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00392-014-0750-y","volume":"104","author":"CA Gleissner","year":"2015","unstructured":"Gleissner, C. A. et al. Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease. Clin. Res. Cardiol. 104, 13\u201322 (2015).","journal-title":"Clin. Res. Cardiol."},{"key":"91679_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/eci.12457","volume":"45","author":"B Wilde","year":"2015","unstructured":"Wilde, B. et al. Phosphorylcholine antibodies are diminished in ANCA-associated vasculitis. Eur. J. Clin. Investig. 45, 686\u2013691 (2015).","journal-title":"Eur. J. Clin. Investig."},{"key":"91679_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.atherosclerosis.2015.10.024","volume":"243","author":"A Imhof","year":"2015","unstructured":"Imhof, A. et al. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease. Atherosclerosis 243, 414\u2013420 (2015).","journal-title":"Atherosclerosis"},{"key":"91679_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2015.12.009","volume":"170","author":"TG Nguyen","year":"2016","unstructured":"Nguyen, T. G. et al. Aberrant levels of natural IgM antibodies in osteoarthritis and rheumatoid arthritis patients in comparison to healthy controls. Immunol. Lett. 170, 27\u201336 (2016).","journal-title":"Immunol. Lett."},{"key":"91679_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/rheumatology\/kez264","volume":"59","author":"P Lopez","year":"2019","unstructured":"Lopez, P. et al. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile. Rheumatology (Oxford) 59, 407 (2019).","journal-title":"Rheumatology (Oxford)"},{"key":"91679_CR25","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/ndt\/gfp309","volume":"24","author":"JJ Carrero","year":"2009","unstructured":"Carrero, J. J. et al. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis. Nephrol. Dial. Transplant. 24, 3454\u20133460 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"91679_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2016.04.007","volume":"166\u2013167","author":"M Rahman","year":"2016","unstructured":"Rahman, M. et al. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms. Clin. Immunol. 166\u2013167, 27\u201337 (2016).","journal-title":"Clin. Immunol."},{"key":"91679_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004415","author":"D Thiagarajan","year":"2016","unstructured":"Thiagarajan, D. et al. Human IgM antibodies to malondialdehyde conjugated with albumin are negatively associated with cardiovascular disease among 60-year-olds. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.116.004415 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"91679_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/jcm9030753","volume":"9","author":"SK Samal","year":"2020","unstructured":"Samal, S. K., Qureshi, A. R., Rahman, M., Stenvinkel, P. & Frosteg\u00e5rd, J. Antibodies against malondialdehyde in haemodialysis patients and its association with clinical outcomes: Differences between subclasses and isotypes. J. Clin. Med. 9, 753 (2020).","journal-title":"J. Clin. Med."},{"key":"91679_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.rinim.2012.01.001","volume":"2","author":"R Fiskesund","year":"2012","unstructured":"Fiskesund, R. et al. IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL. Results Immunol. 2, 13\u201318 (2012).","journal-title":"Results Immunol."},{"key":"91679_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/cei.13441","volume":"201","author":"SK Samal","year":"2020","unstructured":"Samal, S. K., Qureshi, A. R., Rahman, M., Stenvinkel, P. & Frostegard, J. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: Association with mortality. Clin. Exp. Immunol. 201, 94\u2013104 (2020).","journal-title":"Clin. Exp. Immunol."},{"key":"91679_CR31","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.4049\/jimmunol.0804191","volume":"182","author":"Y Chen","year":"2009","unstructured":"Chen, Y., Park, Y. B., Patel, E. & Silverman, G. J. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 182, 6031\u20136043 (2009).","journal-title":"J. Immunol."},{"key":"91679_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2009.05.003","volume":"34","author":"U de Faire","year":"2010","unstructured":"de Faire, U. et al. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: Effects on uptake of oxidized LDL in macrophages as a potential mechanism. J. Autoimmun. 34, 73\u201379 (2010).","journal-title":"J. Autoimmun."},{"key":"91679_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2017.11.010","volume":"268","author":"J Sun","year":"2018","unstructured":"Sun, J. et al. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors. Atherosclerosis 268, 36\u201348 (2018).","journal-title":"Atherosclerosis"},{"key":"91679_CR34","doi-asserted-by":"publisher","first-page":"11010","DOI":"10.1038\/s41598-020-66981-z","volume":"10","author":"D Thiagarajan","year":"2020","unstructured":"Thiagarajan, D. et al. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases. Sci. Rep. 10, 11010 (2020).","journal-title":"Sci. Rep."},{"key":"91679_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/antib8040057","volume":"8","author":"P de Sousa-Pereira","year":"2019","unstructured":"de Sousa-Pereira, P. & Woof, J. M. IgA: Structure, function, and developability. Antibodies (Basel) 8, 57 (2019).","journal-title":"Antibodies (Basel)"},{"key":"91679_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1749-4877.2011.00280.x","volume":"7","author":"PA Iaizzo","year":"2012","unstructured":"Iaizzo, P. A., Laske, T. G., Harlow, H. J., McClay, C. B. & Garshelis, D. L. Wound healing during hibernation by black bears (Ursus americanus) in the wild: Elicitation of reduced scar formation. Integr. Zool. 7, 48\u201360 (2012).","journal-title":"Integr. Zool."},{"key":"91679_CR37","first-page":"455","volume":"220","author":"TL Iles","year":"2017","unstructured":"Iles, T. L., Laske, T. G., Garshelis, D. L. & Iaizzo, P. A. Blood clotting behavior is innately modulated in Ursus americanus during early and late denning relative to summer months. J. Exp. Biol. 220, 455\u2013459 (2017).","journal-title":"J. Exp. Biol."},{"key":"91679_CR38","doi-asserted-by":"publisher","first-page":"e66119","DOI":"10.1371\/journal.pone.0066119","volume":"8","author":"BA Chow","year":"2013","unstructured":"Chow, B. A., Donahue, S. W., Vaughan, M. R., McConkey, B. & Vijayan, M. M. Serum immune-related proteins are differentially expressed during hibernation in the American black bear. PLoS ONE 8, e66119 (2013).","journal-title":"PLoS ONE"},{"key":"91679_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41598-019-57126-y","volume":"10","author":"PG Jorgensen","year":"2020","unstructured":"Jorgensen, P. G. et al. Cardiac adaptation in hibernating, free-ranging Scandinavian brown bears (Ursus arctos). Sci. Rep. 10, 247 (2020).","journal-title":"Sci. Rep."},{"key":"91679_CR40","doi-asserted-by":"publisher","first-page":"20323","DOI":"10.1038\/s41598-020-76346-1","volume":"10","author":"T Ebert","year":"2020","unstructured":"Ebert, T. et al. Insights in the regulation of trimetylamine N-oxide production using a comparative biomimetic approach suggest a metabolic switch in hibernating bears. Sci. Rep. 10, 20323 (2020).","journal-title":"Sci. Rep."},{"key":"91679_CR41","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.4049\/jimmunol.1303035","volume":"192","author":"R Fiskesund","year":"2014","unstructured":"Fiskesund, R. et al. Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult. J. Immunol. 192, 4551\u20134559 (2014).","journal-title":"J. Immunol."},{"key":"91679_CR42","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.4049\/jimmunol.2000437","volume":"205","author":"D Thiagarajan","year":"2020","unstructured":"Thiagarajan, D. et al. Antibodies against phosphorylcholine and malondialdehyde during the first two years of life. J. Immunol. 205, 2109 (2020).","journal-title":"J. Immunol."},{"key":"91679_CR43","first-page":"428","volume":"36","author":"C Lourdudoss","year":"2018","unstructured":"Lourdudoss, C., Ajeganova, S. & Frostegard, J. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls. Clin. Exp. Rheumatol. 36, 428\u2013433 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"91679_CR44","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/ajcn\/nqy380","volume":"109","author":"PJ Curtis","year":"2019","unstructured":"Curtis, P. J. et al. Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial. Am. J. Clin. Nutr. 109, 1535\u20131545 (2019).","journal-title":"Am. J. Clin. Nutr."},{"key":"91679_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/CIRCULATIONAHA.112.122408","volume":"127","author":"A Cassidy","year":"2013","unstructured":"Cassidy, A. et al. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 127, 188\u2013196 (2013).","journal-title":"Circulation"},{"key":"91679_CR46","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.celrep.2016.01.026","volume":"14","author":"F Sommer","year":"2016","unstructured":"Sommer, F. et al. The gut microbiota modulates energy metabolism in the hibernating brown bear Ursus arctos. Cell Rep. 14, 1655\u20131661 (2016).","journal-title":"Cell Rep."},{"key":"91679_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1515\/ap-2018-0019","volume":"63","author":"G Strkolcova","year":"2018","unstructured":"Strkolcova, G. et al. A frequent roundworm Baylisascaris transfuga in overpopulated brown bears (Ursus arctos) in Slovakia: A problem worthy of attention. Acta Parasitol. 63, 167\u2013174 (2018).","journal-title":"Acta Parasitol."},{"key":"91679_CR48","first-page":"205","volume":"63","author":"B Paoletti","year":"2017","unstructured":"Paoletti, B. et al. Helminth infections in faecal samples of Apennine wolf (Canis lupus italicus) and Marsican brown bear (Ursus arctos marsicanus) in two protected national parks of central Italy. Ann. Parasitol. 63, 205\u2013212 (2017).","journal-title":"Ann. Parasitol."},{"key":"91679_CR49","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s00436-017-5456-4","volume":"116","author":"SV Bugmyrin","year":"2017","unstructured":"Bugmyrin, S. V. et al. Helminths of brown bears (Ursus arctos) in the Kola Peninsula. Parasitol. Res. 116, 1755\u20131760 (2017).","journal-title":"Parasitol. Res."},{"key":"91679_CR50","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7589\/0090-3558-35.3.618","volume":"35","author":"RJ Gau","year":"1999","unstructured":"Gau, R. J., Kutz, S. & Elkin, B. T. Parasites in grizzly bears from the central Canadian Arctic. J. Wildl. Dis. 35, 618\u2013621 (1999).","journal-title":"J. Wildl. Dis."},{"key":"91679_CR51","first-page":"1","volume":"46","author":"J Frosteg\u00e5rd","year":"2016","unstructured":"Frosteg\u00e5rd, J., Tao, W., Rastam, L., Lindblad, U. & Lindeberg, S. Antibodies against phosphorylcholine among New Guineans compared to Swedes: An aspect of the hygiene\/missing old friends hypothesis. Immunol. Investig. 46, 1\u201311 (2016).","journal-title":"Immunol. Investig."},{"key":"91679_CR52","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1749-6632.2009.04671.x","volume":"1173","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin, N. et al. Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea. Ann. N. Y. Acad. Sci. 1173, 675\u2013682 (2009).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"91679_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1743-7075-4-7","volume":"4","author":"J Frostegard","year":"2007","unstructured":"Frostegard, J. et al. Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea. Nutr. Metab. (Lond.) 4, 7 (2007).","journal-title":"Nutr. Metab. (Lond.)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91679-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91679-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:36:36Z","timestamp":1670060196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91679-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["91679"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-91679-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JF is named as inventor on patents relating to anti-PC. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12120"}}